Clinical Trial Update: Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery. [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating serum and tissue cefazolin concentrations in normal-weight patients undergoing cesarean delivery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: West Virginia University | Conditions: Infection, Cesarean Delivery | Phase 4 | Status: WITHDRAWN